the

problem

Hospital Acquired Infections (HAI’s) are infections that patients contract while receiving treatment at a healthcare facility.

Despite years of effort and improvement, HAI’s continue to be on the rise as virulent strains of pathogens, including Clostridium Difficile (C. diff), Pseudomonas Aeruginosa, and Methicillin-Resistant Staphylococcus Aureus (MRSA) become increasingly resistant to drug therapies, and as a result increasingly costly to treat. They are a major global threat to patient safety and a large economic burden to healthcare systems. In the U.S. alone, the CDC reports that HAIs affect approximately seven percent of hospitalized patients each year.

In addition to healthcare facilities, the process manufacturing sector, including food, pharmaceutical, and beverage, is also susceptible to bacterial contamination, especially in food preparation areas due to high foot traffic. Cleanrooms, vital in multiple sectors where even minute particles can pose manufacturing risks, including semiconductors, biotech, medical devices, life sciences, aerospace, optics, and defense industries are at risk of bacterial contamination, necessitating stringent hygiene measures.

Read More

Key facts

USA

  • $35 Billion

    Financial burden to worldwide health care system per year.



  • 1.7 Million

    People per year in the U.S. get an infection during a hospital stay.

  • 17.6 Days

    If you contract an HAI your length of stay increases to an average of 17.6 Days.

  • 98,987

    People in the U.S. die annually from an HAI.

The

SOLUTION

Introducing A Footwear Disinfection Station!

UVFLOORx™ has pioneered an automated UV-C and FAR-UV foot disinfection station designed to eliminate deadly pathogens from footwear before individuals enter critical care areas. These areas include hospitals, manufacturing clean rooms, experimental laboratories, pharmaceutical compounding facilities, life science establishments, and food preparation areas.

Equipped with the latest UV-C and FAR-UV Light Source technology, the UVFLOORx™ system swiftly eradicates over 99.9% of potentially harmful microbes in 10 seconds. These cutting-edge light Source, combined with the overall system design, are specifically engineered to deliver the highest bacterial eradication efficiency compared to other Light Source technologies and UV systems.

The energy emitted by the short wavelength UV light is absorbed by the cellular RNA and DNA of microbes, causing damage to nucleic acids and preventing microorganisms from infecting and reproducing. The UVFLOORx™ operates seamlessly, with an expandable operating system that can be tailored to staff compliance and overall usage, providing real-time insights through a variety of scalable integrations.

About Us

UVFLOORx™ developed out of a medical product innovation think tank and was established with the mission to develop and introduce UVFLOORx™ a patented foot disinfection station powered by high-intensity UV light sources. We mitigate the transmission and transport of harmful microbes facilitated by foot traffic and improve healthcare outcomes.

Healthcare facilities, cleanrooms, and food businesses all face the challenge of preventing the introduction of these microbes into sterile or germ sensitive critical areas. Our automated disinfection device, equipped with cutting-edge UVC light source technology, is uniquely positioned to effectively address this challenge.

We are committed to making a significant impact in the UV disinfection market and providing solutions to healthcare facilities and process manufacturing campuses.

Schedule a Demo

Our

management team

Rachel Dombrowsky – Founder & Chairman of the Board
Lorem Ipsum
Kamal Mahajan – Chief Technology Officer
Chief Technology Officer – Lead Designer. Professor Mahajan holds the position of Chief Technology Officer (CTO), providing creative technology inspiration, product design, and final manufacturing oversight and control. For more than three decades, Mahajan has built a leading reputation in system design for the medical sector and healthcare related applications. Including but not limited to,… Continue reading Kamal Mahajan – Chief Technology Officer
Dr. Ira Braunschweig – Chief Medical Advisor
Dr. Braunschweig started the Stem Cell Transplant Program and obtained FACT accreditation for Autologous, Allogeneic Matched Related, Allogeneic Matched Unrelated and Haploidentical Transplants at Montefiore Medical Center. Started the Cell Therapy Program (CART therapy) at Montefiore Medical Center and obtained “center of excellence” designation for CD19 CART therapy. Recipient of a 2 million dollar grant… Continue reading Dr. Ira Braunschweig – Chief Medical Advisor

UVFLOORx™: Setting New Standards in UV-C and FAR-UV Foot Disinfection.

Do you want to know more about our product?

Our

Client Experience

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

-Lorem Ipsum

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

-Lorem Ipsum

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

-Lorem Ipsum